PTEN deletion data were compared with clinico‐pathological parameters in pTa and pT2‐4 carcinomas and clinical outcomes in pT2‐4 carcinomas, immunohistochemical p16 and p53 expression, and TP53 copy number status measured by FISH from previous studies. This evidence concerns the gene TP53 and carcinoma.